Production (Stage)
Kronos Bio, Inc.
KRON
$0.872
$0.00210.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.36M | -25.81M | -14.11M | -16.20M | -29.96M |
| Total Depreciation and Amortization | 220.00K | 409.00K | 412.00K | 420.00K | 475.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.21M | 17.84M | 2.07M | 2.74M | 14.18M |
| Change in Net Operating Assets | -7.91M | -5.27M | -740.00K | -3.29M | -8.59M |
| Cash from Operations | -12.84M | -12.84M | -12.37M | -16.33M | -23.90M |
| Capital Expenditure | -- | -4.00K | 7.00K | 0.00 | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.85M | 22.36M | 17.12M | 40.18M | 5.78M |
| Cash from Investing | 19.85M | 22.36M | 17.13M | 40.18M | 5.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 82.00K | -- | 164.00K | -- |
| Repurchase of Common Stock | -- | -- | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 82.00K | -1.00K | 164.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.01M | 9.61M | 4.76M | 24.01M | -18.13M |